Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 975 Records) |
Query Trace: FLT3[original query] |
---|
Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations. Leukemia research reports 2023 9 20 100385. Zhuang Zuo, L Jeffrey Medeiros, C Cameron Y |
Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia-Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022. Cancers 2023 9 15 (18): . Ma?gorzata Czoga?a, Wojciech Czoga?a, Katarzyna Pawi?ska-W?sikowska, Teofila Ksi??ek, Karolina Bukowska-Strakova, Barbara Sikorska-Fic, Pawe? ?aguna, Anna Fa?kowska, Katarzyna Drabko, Katarzyna Muszy?ska-Ros?an, Maryna Krawczuk-Rybak, Marta Koz?owska, Ninela Irga-Jaworska, Karolina Zielezi?ska, Tomasz Urasi?ski, Natalia Bartoszewicz, Jan Styczy?ski, Jolanta Skalska-Sadowska, Jacek Wachowiak, Anna Rodziewicz-Konarska, Krzysztof Ka?wak, Ma?gorzata Ciebiera, Rados?aw Chaber, Agnieszka Mizia-Malarz, Agnieszka Choda?a-Grzywacz, Gra?yna Karolczyk, Katarzyna Bobeff, Wojciech M?ynarski, Katarzyna Mycko, Wanda Badowska, Renata Tomaszewska, Tomasz Szczepa?ski, Katarzyna Machnik, Natalia Zamorska, Walentyna Balwierz, Szymon Skocz |
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers 2023 9 15 (18): . Jan Korbecki, Patrycja Kupnicka, Katarzyna Barczak, Mateusz Bosiacki, Pawe? Zi?tek, Dariusz Chlubek, Irena Baranowska-Bosiac |
[Characteristics of genetic variants in 134 patients with Acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 9 40 (10): 1222-1227. Miao He, Xiaochen Zhao, Hongjuan Tian, Shuting Zhang, Fangqing Zhao, Xi Zhang, Tao |
Morphological, cytogenetic and molecular characterisation of FLT3 mutations in Pakistani patients with de novo acute myeloid leukaemia: A single centre experience. The Malaysian journal of pathology 2023 9 45 (2): 205-214. M Faiz, F Rash |
Prognostic impact of FLT3-ITD mutation on NPM1 acute myeloid leukaemia patients and related molecular mechanisms. British journal of haematology 2023 8 . Xin'an Pan, Yingjun Chang, Guorui Ruan, Fangfang Wei, Hao Jiang, Qian Jiang, Xiaojun Huang, Xiaosu Zh |
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia 2023 8 . Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold N Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhn |
Distinct karyotypic and mutational landscape in trisomy AML. British journal of haematology 2023 12 . Stephen S Y Lam, Sze P Tsui, C Y Fung, Nicole Y Saw, Asif Javed, Alvin H W Ip, Edmond S K Ma, Anskar Y H Leu |
[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 12 44 (10): 845-850. L L Wang, S N Ch |
Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia. Asian Pacific journal of cancer prevention : APJCP 2023 12 24 (12): 4301-4307. Omnia Kaheled, Salah Aref, Nadia El Menshawy, Mohamed Aref, Mohamed Ay |
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 2023 12 30 (12): 10410-10436. Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Sch |
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology 2023 12 . Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Teffe |
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients. European journal of haematology 2023 11 . C Petit, C Saillard, B Mohty, Y Hicheri, F Villetard, V Maisano, A Charbonnier, J Rey, E D'Incan, C Rouzaud, V Gelsi-Boyer, A Murati, A C Lhoumeau, A Ittel, M J Mozziconacci, A S Alary, M-A Hospital, N Vey, S Garci |
Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations. Open medicine (Warsaw, Poland) 2023 11 18 (1): 20230830. Li Sheng, Yajiao Liu, Yingying Zhu, Jingfen Zhou, Haiying H |
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. Pharmacogenomics and personalized medicine 2023 11 16 1011-1026. Rui Huang, Yi-Ting Zhang, Yu Lin, Ru-Li Pang, Zhi Yang, Wei-Hua Zh |
Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. Clinical laboratory 2023 11 69 (11): . Eunhee Han, Soorack Ryu, Dohyang Kim, Eun-Ha Koh, Jung-Hyun Byun, Dong-Hyun L |
Rare variant associations with plasma protein levels in the UK Biobank. Nature 2023 10 622 (7982): 339-347. Ryan S Dhindsa, Oliver S Burren, Benjamin B Sun, Bram P Prins, Dorota Matelska, Eleanor Wheeler, Jonathan Mitchell, Erin Oerton, Ventzislava A Hristova, Katherine R Smith, Keren Carss, Sebastian Wasilewski, Andrew R Harper, Dirk S Paul, Margarete A Fabre, Heiko Runz, Coralie Viollet, Benjamin Challis, Adam Platt, , Dimitrios Vitsios, Euan A Ashley, Christopher D Whelan, Menelas N Pangalos, Quanli Wang, Slavé Petrovs |
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients. Annals of hematology 2024 5 . Yu Shi, Xiao Chen, Huimin Jin, Liying Zhu, Ming Hong, Yu Zhu, Yujie Wu, Hairong Qiu, Yan Wang, Qian Sun, Hui Jin, Jianyong Li, Sixuan Qian, Chun Qi |
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood 2024 5 . Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Frances Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Kenneth Burnett, Charlotte S Wilhelm-Benartzi, Brian Jp Huntly, Nigel H Russell, Richard James Dill |
Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis. Hematology (Amsterdam, Netherlands) 2024 4 29 (1): 2346965. ZhongLi Hu, YanLi Yang, JiaJia Li, ZhongTing |
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Molecular diagnosis & therapy 2024 4 . Youngeun Lee, Soo Hyun Seo, Jinho Kim, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kyoung Un Park, Sang Mee Hwa |
[Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with GATA2 Gene Mutation]. Zhongguo shi yan xue ye xue za zhi 2024 4 32 (2): 327-334. Ruo-Qi Shan, Sai Huang, Zhen-Yang Gu, Nan Wang, Dai-Hong Liu, Li-Ping D |
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. Leukemia research 2024 4 140 107497. Alberto Risueño, Wendy L See, Iryna Bluemmert, Stéphane de Botton, Courtney D DiNardo, Amir T Fathi, Andre C Schuh, Pau Montesinos, Paresh Vyas, Thomas Prebet, Anita Gandhi, Maroof Has |
FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia-Even in the Era of New Treatment Modalities Still a Significant Player. Journal of clinical medicine 2024 4 13 (7): . Saša Anžej Doma, Matjaž Sever, Gorazd Jakoš, Helena Podgorn |
Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India. Journal of hematopathology 2024 1 16 (1): 17-25. Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Sin |
Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata. Frontiers in endocrinology 2024 1 14 1309620. Xue-Yong Zheng, Yan-Ping Ma, Bo Zhang, Yan-Xin Chen, Lei Tang, Xiao-Hua Tai, Jia-Hao C |
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. American journal of hematology 2024 1 . Nour Moukalled, Myriam Labopin, Jurjen Versluis, Gérard Socié, Didier Blaise, Urpu Salmenniemi, Alessandro Rambaldi, Tobias Gedde-Dahl, Eleni Tholouli, Nicolaus Kröger, Jean-Henri Bourhis, Peter Von Dem Borne, Etienne Daguindau, Edouard Forcade, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Moh |
Prognostic impact of CEBPA mutational subgroups in adult AML. Leukemia 2024 1 . Julia-Annabell Georgi, Sebastian Stasik, Michael Kramer, Manja Meggendorfer, Christoph Röllig, Torsten Haferlach, Peter Valk, David Linch, Tobias Herold, Nicolas Duployez, Franziska Taube, Jan Moritz Middeke, Uwe Platzbecker, Hubert Serve, Claudia D Baldus, Carsten Muller-Tidow, Claudia Haferlach, Sarah Koch, Wolfgang E Berdel, Bernhard J Woermann, Utz Krug, Jan Braess, Wolfgang Hiddemann, Karsten Spiekermann, Emma L Boertjes, Robert K Hills, Alan Burnett, Gerhard Ehninger, Klaus Metzeler, Maja Rothenberg-Thurley, Annika Dufour, Hervé Dombret, Cecile Pautas, Claude Preudhomme, Laurene Fenwarth, Martin Bornhäuser, Rosemary Gale, Christian Thie |
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2300943. Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dillon, Steven Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: